Single-dose methotrexate for the treatment of ectopic pregnancy: Our experience from 2010 to 2015

Authors

  • Emre Erdem Taş Y?ld?r?m Beyaz?t University
  • Gülin Feykan Feykan Ye?in Ak Y?ld?r?m Beyaz?t University
  • Ayse Filiz Avsar Y?ld?r?m Beyaz?t University

DOI:

https://doi.org/10.12669/pjms.331.11238

Keywords:

Ectopic pregnancy, β–human chorionic gonadotropin, Methotrexate, Single injection.

Abstract

Objective: To evaluate the success of systemic single-dose methotrexate (MTX) treatment in patients with ectopic pregnancy (EP) and to investigate factors related to treatment success.

Methods: This retrospective study had been performed in Yildirim Beyazit University between January 2010 and December 2015. Demographic and clinical characteristics, ultrasonografic findings, pretreatment serum ?

Author Biographies

Emre Erdem Taş, Y?ld?r?m Beyaz?t University

Department of gynecology and obstetrics

Gülin Feykan Feykan Ye?in Ak, Y?ld?r?m Beyaz?t University

Department of gynecology and obstetrics

Ayse Filiz Avsar, Y?ld?r?m Beyaz?t University

Department of gynecology and obstetrics

Downloads

Published

2017-02-07

How to Cite

Taş, E. E., Ye?in Ak, G. F. F., & Avsar, A. F. (2017). Single-dose methotrexate for the treatment of ectopic pregnancy: Our experience from 2010 to 2015. Pakistan Journal of Medical Sciences, 33(1). https://doi.org/10.12669/pjms.331.11238